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The complete cDNA structure or the porcine (p) pro-protein and pro-hormone convcrtase PC2 (pPC2) was obtained from a cDNA library of 
pituitary neurointcrmcdiatc lobes mRNA. The dcduccd amino acid sequence r vealed that pPC2 exhibits a99-978 sequence identity to the human, 
mouse and rat homologues. The 3’ end of the 2.1 kb cDNA is the least conserved segment. On Northern blots of pars intcrmcdin poly A* RNA 
two transcripts of 3 and 5 kb were detected. Molecular analysis of the N-terminal glycopcptide products of porcine pro-opiomclonocortin (pPOMC) 
co.expresscd with vaccinia virus recombinants of PCI or PC2, rcvcaled that in cells devoid or containing sccrctory granules both convertascs an 
cleave pPOMC with PC1 releasing ~11e I-50, I-107 and I-148 glycopptide fragments. and PC2 cleaving pPOMC directly into pPOMC l-107. 
Porcine PC2; Pro-hormone convertase; Vaccinia virus uxprcssion; POMC N-terminal glycopcptidc cleavage 
1, INTRODUCTION 
Polypeptide hormones, certain hormonal receptors, 
growth factors and many viral surface glycoproteins are 
activated by the specific processing of their precursor by 
endogenous intracellular proteinases. The mammalian 
enzymes responsible for this process have recently been 
identified and were found to belong to the subtilisin 
family of serine proteinases [l]. At least 5 distinct mem- 
bers of this family have now been identified and se- 
quenced. These include PCI [2,3], PC2 [2,4], furin [S], 
PACE4 [6] and PC4 [7,8]. These enzymes fall into three 
groups: those which are ubiquitously expressed such 3s 
furin [S] and PACE4 [6], those which are expressed only 
in endocrine and neuroendocrine cells, such as PC1 and 
PC2 [2-4,9], and finally PC4 which is only expressed 
within testicular [7,8] and ovarian germ cells [S]. 
Cellular co-expression of furin, PC1 and PC2 with 
polypeptide precursors revealed that these enzymes ex- 
hibit exquisite selectivity of cleavage post-pairs of basic 
residues [IO, 111. The POMC processing by PC1 and 
PC2 has now been well documented for the ACTH/ 
aMSH andBLPH/,BEndorphin segments of this precur- 
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sor [lo]. Accordingly and in agreement with in situ cel- 
lular localization studies [9], PC1 would be responsible 
for the production of ACTH and BLPH with some j?En- 
dorphin while PC2 would produce /IEndorphin and to- 
gether with PCl, carboxypeptidase E, the amidation 
enzyme and an N-acetylating enzyme would then gener- 
ate aMSH [IO]. The manufacture of aMSH is favored 
in cells containing secretory granules. 
In this paper, we undertook the complete cDNA 
characterization of porcine pituitary pars intermedia 
PC2 and show that the evolutionary conservation of 
sequence for PC2 is greater than that for PC1 [12]. We 
also compared the cleavage selectivity of PC1 and PC2 
for the N-terminal glycopeptidc segrnerlt of the POMC 
molecule and show that both convertases can process 
the N-terminal segment of porcine POMC with PC1 
generating pPOMC l-80, I-107 and l-148 and PC2 
producing pPOMC l-107 directly. 
2. MATERIALS AND METHODS 
2.1. Clottittg of porcine piruitury neuroitrra~ttrr~~ fobr pPC2 
Using lOO,ug orpoly A+ RNA from porcine pituitary neurointermc- 
diate lobes, a size sclcctcd (> I kb) cDNA library was established in
a pcDNA II vcc1or. This cDNA library was screened with a full-length 
mouse PC2 cDNA probe rddiolahclcd with [a-“P]dCTP as described 
[I!]. FilIccn positive clones were isolated out oi a total of SOO.tJOO 
colonies creened. The ion@ clone is&M cth&A B 2.i tb insert 
and was further anaiysed for complete DNA scqucncc dacrminatian 
as dcscri bed [2]. 
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2.2. Vuccirliu sit-us recoatbitruttts of ~JIPCI, ntPC2, pPOMC attd celh- 
fw ittfLJcfbtls 
The purilied recombinant vaccinia viruses (VV) using lhe full-length 
cDNA inserts of mouse PCI [3] (WmPCI) and mouse PC2 [2] 
(VV:mPC2) were the same as those previously reported [IO]. The 
porcine POMC vaccinia virus recombinant (VV:pPOMC) was pm- 
pared from the cDlr;A of porcine POMC [I31 using the PML601 
lransfer vector [14]. The cellular infections of BSC40 and PC12 cells 
were done as described [IO], consisling of the co-infection of lhe 
VV:pPOMC (2 pfulcell) with either 4 pfu/cell tif the wild type virus 
(VV:WT) or the recombinanls VV:mPCI or VVxnPC2 or 2 pfu/cell 
of each VV:mPCI and VV:mPC2. 17 h post-infections, the cells were 
washed and incubated for 7 h, and the culture media analysed. 
Proleins incuhure mcdiawereseparated by SDS-PAGE usinga 14% 
(w/v) acrylamide slab gel system, and then transfered ekctrophoreti- 
tally Lo nitrocellulose membranes, which were incubated for 4 h with 
two monoclonal antibodies, Mab 2-197 and Mab l-244 dircctcd 
agains~theNMI-terminalglycopep~idesegmentofporcine POMC,as 
described [IS]. The porcine markers pPOMC l-241 and pPOMC 
l-148 were obtained by expression of full length and truncated 
pPOMC cDNAs in COS-I cells. 
3. RESULTS AND DISCUSSION 
3. I. cDNA sequence ardysis of pPC2 
From the 2 140 nucleotides (nt?) sequence presented 
in Fig. 1, we observe an open-reading frame containing 
1914 bp. A variant polyadenylation signal AATACA is 
present as well as the poly A tail appearing 15 nts later. 
Similar to mPC2 [?,I l] a 25 amino acids signal peptide 
is predicted (Fig. I), the cleavage of which would result 
-25 -PO -10 "111 
MetLysGlyClyCysValSerClnTrpLysAlaAlaAlaGlyLeuLeuPheCysValThrValPheAlaSerAlaGl~ArpProValPheThr 
AhCACCACTTTTCACTCCCAAAGAAACATGATG~GGTCGCTGTGTCTCCCA~GG~GGCGGCCGCCGGG~C~~~~CA~~TCC~~~GCCG~CAC~GT~CACA 
10 20 30 M 
AsnHlsPhai~uValC;iuLeuHIsLysGlyGlyGluGluGluAlaArgGlnValAl~laGlu~isGly~heGlyVal~LQuProPhQAlaGlu~iyLeuTyrHisPheTyr~is 
hATCATTTTCTTGTGGAGTTGCATAhr3CGCGGAGAGAGG~C~G~CGCC~G~~GCAGCAG~CA~C~~GGAGTCCG~GC~C~G~G~GGC~GTACCA~ATCAC 
50 60 70 80 
AsnGlyLeuA1aLysAla~SerLauHisUisLysG~nArgLeuGluArgAspProArgVal~AlaLeuGlnGlnGluGlyPheAsp~lyTyr 
AATGGC~GGCAAACCCCAAGAGAAGACGCAGCCTACACCATAAGCAGCGGCTGGAGAGAGACCCCAGGGT~GAGAG~GC~CAGG~GG~CGATCGG~GffiAGG~AT 
90 100 110 120 
-_- 
TrpGluLeuGlyTyrThrClyLysGlyValThrIlaGlyfleMet~AspGlyIleAspTyrLeuHlsProArpLeuAlaSerAsnTyrAsnAl~Gl~~~5erTyrAs~PheSerSQr 
TGCCAG~GCCATACA~GG~GGTCTTACCA~GC~~ATGGACGATGG~TCGA~AT~CCACCCGGAC~GGC~CG~CTAC~TGCGG~GCGA~~ACGA~TAGCAGC 
170 180 n 190 200 
AsnAspFroTyrProTyrProArgTyrThrAspAspTrpPheAsnSer~GlyThrArgCysAlaGlyGluValSerAl~l~l~snAsnAsn~lQCysGlyValGlyValAlaTyr 
MCGACCCCTACCCTTACCCTCGCTACACAGACGACTGGTIGCCGCAGCC~CAACAATATCTGCGGGGTTGGACTGGCCTAC 
210 220 230 240 
ScrScrLysVali3laGlyileArgMQtLeuAspGlnProPheMetThrAspTlQIleGluAlaSerSorIleSerllisMetProGlnLcuIlQAspIlaTyrSerAlaSerTrpGlyPro 
AGCTCCAAGGTTGCAGGTATCCGGATGCPGGACCAGCC~TCATCAC~~ACATCATCGAGCCCTCTTCCATCACCCACATGCCTCAGCPAATTGACATLACAGCGCCAGCTCGGGCCCC 
250 260 270 280 
ThrAspAsnClyLysThrYalAspGlyProArgCluLeuThrLeuClnAla~etAlaAspGlyVolAsnLysClyArg~lyClyLysClySerI:leTyrValTrpAlaSerCly~~ly 
ACCGACAACGCCAAGACGCTGGACGGGCCGCCGGAGCTCACG~CAGG~ATGGCCGACGGTGTG~C~~GGCCGAGGGGGCAAAGGCAGCATCTACGTGTGGGCCTCCGGCGACGGT 
290 300 310 320 
GlySerTyrAspAspCysAsnCysAspGlyTyrAlaSerSerHetTrpThrIleS@rIleAsnSerAlaIleAsnAspGlyArgThrAlaLeuTyrAspGluSerCysSar5crThrLQu 
GGCAGCTACCACCACTGCMCGTGACCCCTATCCCTCCAGCATGTGGACCATCCCATC~CTCTGCCATCAACGACGGCAGGACCGCCCTCTACGACGAGAGAGCTGCTC~CCAC~G 
330 340 R** n 360 
AlaSerThrPheSerAsnClyAr~L!f.@q AsnProGluAlaGlyValAlaThrThrAspLeuTyrGlyAsnCysT~~rLeuArgHisSQrGlyThr~Al~l~laPraGl~l~la 
GCCTCCAC~~GCAATGGGPAGAGGAGG~CCCCGAGGCCGGC~GGCAACCACACA~GTACCGC~~G~~~GAGGCA~~GGGACATCCG~G~G~CCTGAGGCAG~ 
380 390 400 
GlyValPheAlaLeuhlaLeuGluAlaAsnLeuGlyLeuThrTrpAr~Asp~etGlnHisLeuThrValLeuThrSerLvsAr~AsnGlnLeuH~sAspGluValHisClnTrp~ 
CGAGn;TTTCCACTCGCAGACG~~CCTGGGT~GAC~GGAGAGACATGCAGCAT~GACCGTG~CAC~CC~CGG~CC~CTTCATGATGAGGTC~TCA~GGC~AGA 
410 420 430 A4a .-- .__ _ ._ 
AsnGlyValGlyLeuGluPheAsnRisLeuPheGlyTyrClyValLeuAspAlaGlyAlaMetValLysHetAlaLysAspTrpLysThrValProGluArgPheEiaCysValGlyGly 
AACGGAGTCGGC~AGAG'PTTAATCAC~C~TGGCTATGGAGTC~TGACGCAGGGGCCATG~G~TGGCT~GACTCG~CCGTGC~GAGAGA~C~~GTGTG~~AGGC 
450 460 470 490 
SerValGlnAspProGluLysl:leProSerThrGlyLysLeuValLeuThrLeuThrThrAspAlaCysGluGlyLy~GluAsnPheValArgTyrLeuGluHisValGlnAlaValTle 
TCCGTACACGACC~GAACCATCCA~G~~~GCTG~GAffi~CACCAC~ATGCATGTGAGGGG~GG~~CGTCCG~AC~GGAG~C~CC~G~GT~TC 
*49rl ***!iOO 510 520 
ThrValAsnAlaThr~~ly~pLeuAsnIleAsnNctThrScrProMetGlyThrLysSerTleLQuLauSer~ProArgAspAspAspSerLysValGlyPheAspLys 
ACGGTCAATCCGACCCGGAGAGGAGACCTGAACATTAACATGACATCCCCCATGGGCACC~GTCCATC~GC~AGCCGGCGCCCGAGGGAC~AC~A~C~GGTGGG~CGA~G 
530 540 550 560 
TrpProPheMetThrThrBisThrTrgGlyGlyGluAspAl~r~lyThrTrpThrLeuGluLQuGlyPheValGlySerAlaPro~lnLys~lyAlaValLyaGluTrpThr~u~etLeu 
TGGC~TCATGACCACCCACAC~GGGGGGA~ATGCCC~AGGCACCTGGACCC~GAG~AGG~~GTGG~AGCGCACCCCA~~GGGGGCTGTG~~GAGT~GACGCT~TG~G 
570 580 590 600 
HieGly5erGlnSerAlaProTyrIleAspGlnValYalArgAspTyrGlnSerLysLe~laHa~Ser~GluGluLauGluGluGluLe~s~l~laValGl~rgSerLeu 
CACGCCAGCCACACCGCCCCTACATCGACCAGGTGGTGAGCGA~ACCAGTCC~~~G~CGCCAT~CC~G~G~~~AGC~G~AGG~GAGCTGGACG~GCAGTGGAGA~GC~G 
610 613 
LysSerIleLeuGlyLysHis 
AAGAGCATCCTCGCCAACCACPACCCCACCTCCTGGC~CCGCCGCCGCC~GCCCGA~~GC~CTGTC~CG~CCACATCCCACCCATCGC~~C~TCA~~CCCCCGACCC 
120 
240 
360 
600 
720 
a40 
960 
1080 
1200 
1320 
1440 
1560 
1680 
1800 
1920 
2040 
2100 
Fig. I. Complete cDNA and the deduced amino acid sequence ol’ pPC2. The active site Asp, HP, and ScP, and khe imponant Asp residue, as 
well as the lhree potential N-plycosylation (***) sites and the IKiD sequence are emphasized. The predicted sites of the signal peptidnse cleavage 
and zymogcn activation [2,l I] are dcpictcd by an arrow and an inverted triangle, repsectively. The 6 pairs of basic residues, atribnsic and the two 
letrabasic residues are emphasized. The variant polyadcnylation signal AATACA is underlined. 
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in a 613 amino acids long proteinase. Recently, we 
showed that PC1 and PC2 are first synthesized as prc- 
cursor enzymes (zynzogens) which undergo post-trans- 
lational modifications leading to the excision of their 
N-terminal pro-segment via the cleavage at a specific 
LysArg-sequence [ 111, Therefore, similar to mPC2, we 
expect hat pPC2 would be first synthesized as a zymo- 
gen with an 84 amino acid pro-segment which is then 
cleaved at the ArgLysLysArg941 sequence to release the 
active enzyme. The mature enzyme would therefore 
contain 529 amino acids and three potential Asn-glyco- 
sylation sites (Fig. 1). The protein sequence deduced 
from the cDNA structure of pPC2 shows the presence 
of the three active site amino acids Asp14’, HisIs and 
Ser359 at similar positions to the equivalent residues 
found in PC2 of mouse [23, human [4], rat 1161 and 
Xenoptw [173 and in subtilisins [18]. Furthermore, pPC2 
also contains the important Apples, which replaces the 
usually found Asn reported to play a crucial role in 
stabilizing the oxyanion hole in subtilisins [19]. From 
Fig. I, we notice the presence of an ArgArgGlyAspLeu 
sequence (residues 492-496), which is identical to that 
found in PC1 [3,12] PC2 [2,4], furin [S], PACE4 [63 and 
PC4 [7,8]. The tripeptide ArgGlyAsp (RGD) represents 
the minimal recognition sequence for cell surface recep- 
tors known as integrins, which are important for func- 
tions such as cell adhesion [20]. The role of this con- 
served RGD sequence in any of the identified conver- 
tases is still unknown. Finally, as in all PC2 structures 
reported and similar to carboxypeptidase E 1211 we also 
observe the presence of a C-terminal amphipathic struc- 
ture which may allow pPC2 to be membrane associated 
in a pH-dependent manner. It is interesting to note that 
the C-terminal amino acid of pPC2 is His while all other 
28- 
1234 567691011 
kDa 
-36.6 
-23 
-16 
PC2 structures reported end in Asn [2,4,16,17]. The 
pPC2 protein structure is highly conserved exhibiting an 
overall sequence identity to human, mouse, rat and X&I- 
opus PC2 of 97.58, 95.88, 95.6% and 86.78, respec- 
tively. This homology of sequence of PC2 is more pro- 
nounced than that of PC1 which exhibits a 92.6% se- 
quence identity between human, mouse and rat PCl 
[S, 16,221. 
Similar to what was already described for mouse [2], 
human [4] and rat [9] PC2, Northern blot analysis of the 
poly A+ RNA obtained from porcine neurointermedi- 
ate lobes demonstrated the presence of a major 3 kb and 
a minor 5 kb transcript (not shown). By analogy to what 
was reported regarding the 5 kb form of rat [22] and 
human [12] PCl, this mRNA size for pPC2 could also 
represent a 3’ extended form of the 3 kb, probably due 
to the utilization of an alternative polyadenylation site. 
3.2. Processing of pPOMC by PC1 und PC2 
In order to complete our earlier studies on the proc- 
essing of POMC by PC1 and PC2, WC undertook the 
analysis of the N-terminal glycopeptide cleavage pat- 
tern of pPOMC by PCI and PC2 in both BSC-40 cells 
which are devoid of secretory granules and in PC12 cells 
which contain secretory granules. For this purpose, we 
co-infected these cells with vaccinia virus recombinants 
of pPOMC and of either mPC1 or mPC2 or both. The 
media were analysed for the N-terminal glycopeptide 
fragments using two monoclonal antibodies: Mab l- 
244 which recognizes an epitope located within the c3- 
meianotropin sequence (resi-dues 51-80 of pl?OMC) 
and Mab Z-197 which binds specifically to a determi- 
nant in the 1-49 segment of pPOMC [13,15], and both 
antibodies recognize the pPOMC l-80 or the bovine 
8 
kDa kDa 
1 2 3 4 5 6 7 8 9 10 11 
Fig. 2, SDS-PAGE/Western blot analysis of culture media proteins ecreted from either BSC40 (A) or PC12 (B) cells infcctcd with W:pPOMC 
at 2 pf&z!! and VVzm?C! an&or VVxnPC2 as indicated. The PCI- or PC%specific pPOMC N-terminal glycopcplidc (NT) digestion products 
were rcvcalcd using two NT-pPOMC-sp&flc monoclonal antibodies. as described inthe methods md in [ IS]. Lane 1, cullure medium irom control 
COS-I c&i; lanes 2.3 porcine pPOMC I-241 and l-148 markers; lanes 4.5 bovine bPOMC 1-77 and 1-49 markers; lane G, VV:mFCl at 4 pfu/ccll; 
lane 7. VV:mPC2 at 4 pfulcell; lane 8, VV:mPCI and VV:mPC2 each at 2 pfu/ccll; lane 9, VV:mPCl at I pfticell and W:mPC2 al 4 pfu/ccll; lane 
10, the control vaccinia virus wild gyp VV:WT at 4 pfu/ccll; lane II, culture medium from either BSC40 (A) or PC12 (B) cells. 
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Fig. 3. Composite model representing the end products of POMC processing by PC1 and PC2. Tbc major and minor cleavage sites following pairs 
of basic residues, are represented by heavy and light arrows, respectively. The amino acid sequence tit the cleavage sites is also shown, The numbers 
rcprercnt he start and end positions of the processed pcptidcs based on the reported POMC scquencc of pPOMC [ 151. The IV- and O-glycosylation 
(CHO) sites PS well as the pairs of basic residues are emphasized. 
bPOMC 1-77 [lS]. In general, the data in Fig. 2A and 
B show that PC1 and PC2 cleaved the N-terminal 
glycopeptide segment of pPOMC with higher efficiency 
in PC12 cells as compared to BSC-40 cells. This is in 
agreement with our earlier analysis of the cleavage of 
the C-terminal ACTH//?LPH segment of POMC by 
these convertases [lo]. Fig. 2A and B show the follow- 
ing: (a) a doublet migrating close to pPOMC 1-148 (i.e. 
ending with the ACTH sequence) only seen with PC1 
in both BSC-40 and PC12 cells (lane 6); (b) in both 
BSC-40 and PC12 cells with PC1 (lane 6) and only in 
PC12 cells with PC2 (Fig. 2B, lane 7) we see a major 
doublet with a molecular weight intermediate between 
bPOMC l-77 and pPOMC l-148, most probably rep- 
resenting pPOMC I-107 which ends with the joining 
peptide sequence [13,23]; (c) only with PC1 in PC12 cells 
can we detect a band migrating at the position of 
bPOMC l-77, most probably representing pPOMC l- 
80 [13,23,24]; (d) with the conditions and cell types used 
we could not detect an immunoreactive peptide migrat- 
ing close to bPOMC l-49 with either enzyme; (e) PC1 
and PC2 act independently, since the co-expression of 
both enzymes at equal levels (lane 8) or 4 times more of 
PC2 over PC1 (lane 9) did not change the relative abun- 
dance of the products as compared to those obtained 
had we summed both enzymatic activities, i.e. the sum 
of the products in lanes 6 and 7. 
The conclusions drawn from the above exp&~~;ent 
suggest hat PC1 is more efficicent han PC2 in cleaving 
pPOMC into pPOMC I-80, while PC2 cleaves pPOMC 
with the direct production of pPOMC I-107 without 
detectable intermediate pPOMC 1-148 (Fig. 2B, com- 
pare lanes 6,7). Therefore, the combination of these 
resuits and those obtained previousiy IlOj aiiow us to 
propose the model shown in Fig. 3, for the POMC 
processing by either PC1 or PC2. It is interesting to note 
that under the conditions chosen of vaccinia virus ex- 
238 
pression and using either BSC-40 or PC12 cells, we did 
not observe the production of pPOMC l-49, known to 
be inefficiently produced in the pituitary pars interme- 
dia [25]. Since this cleavage occurs late during the intra- 
cellular transport route [25], it may therefore be affected 
by the vaccinia virus expression system which does 
change somewhat he intracellular organization of the 
cell. Alternatively, the intracellular and intragranular 
environment conditions within the pituitary pars inter- 
media are not mimicked in either the BSC-40 or PC12 
cells used in this study, and hence the cleavage condi- 
tions may not be optimal for such an inefficient cleavage 
reaction, which in vivo in the pars intermedia never 
exceeds 50% [25]. Finally, it is also possible that the 
AsnProArglLys cleavage needed for the production of 
pPOMC l-49 and Lys-y,MSH [13] in the pituitary pars 
intermedia is effected by another enzyme not yet identi- 
fied. 
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